AVEO Pharmaceuticals, Inc.
Clinical trials sponsored by AVEO Pharmaceuticals, Inc., explained in plain language.
Now part of
LG Chem Ltd.
051910
KRX
Biopharmaceutical company focused on oncology therapies.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug aims to reverse wasting in cancer patients Results expected Dec 2026 (estimated)
- New drug cocktail aims to extend life in Tough-to-Treat head and neck cancer Results expected Aug 2027 (estimated)